• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDEAVOR RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDEAVOR RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Thrombus (2101); Injury (2348)
Event Date 11/25/2019
Event Type  Injury  
Manufacturer Narrative
Literature reference: 10.1016/j.Jacc.2019.11.058.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The aim of this study was to assess the frequency and predictors of very late stent-related adverse events by stent type more than one year after percutaneous coronary intervention.The dataset consisted of 25,032 patients from 19 trials; 3,718 (14.9%), 7,934 (31.7%), and 13,380 (53.5%) patients were treated with bare metal stents (bms), first generation drug-eluting stents (des1), second generation drug-eluting stents (des2), respectively.Medtronic stents implanted included endeavor, resolute integrity and endeavor resolute stents.Patients implanted with des2 were assessed within one year and for a median duration of 4.1 years post stent implantation.Clinical outcomes reported in the study population included all cause death, cardiac death, target vessel myocardial infarction (mi) and non-target vessel mi, stent thrombosis and target vessel revascularization and non-tvr.Data confirmed that des2 were associated with lower rates of very-late major adverse cardiac events (mace), target lesion failure, mi, and stent thrombosis compared with des1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDEAVOR RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
IE 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
IE  
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
IE  
091708734
MDR Report Key9779878
MDR Text Key189305112
Report Number9612164-2020-00976
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P060033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Reporter Occupation Physician
Type of Report Initial
Report Date 03/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/18/2020
Initial Date FDA Received03/03/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
-
-